Memorial Sloan Kettering Cancer Center researchers, led by first-author Sarah Borderud, claimed on September 22, 2014, that e-cigarettes did not help cancer patients quit smoking (media story here). They based that statement on a study they published online in Cancer, a journal of the American Cancer Society (abstract here).
The association of tobacco use and body weight has long been a matter of concern. In 2004, I collaborated with Swedish investigators to publish the first research on whether switching from cigarettes to smokeless tobacco blunts some of the weight gain normally seen with quitting via abstinence (abstract here, blog post here).
Publishing a study of tobacco-specific nitrosamines in American smokeless tobacco products (abstracthere), Dorothy Hatsukami and colleagues at the University of Minnesota called for the FDA to issue “regulations…to reduce levels of…NNK and NNN in smokeless tobacco products to the lowest levels possible.” The authors make illogical and unscientific claims in their article and media interviews (here).
The New England Journal of Medicine yesterday published a letter claiming that vapor contains “hidden” formaldehyde at far higher levels than cigarettes (here), which made headlines worldwide. That conflicts with a report I discussed last week, documenting that formaldehyde levels in e-cigarettes were far lower than those in traditional cigarettes (here).
As noted previously (here), Drs. Karl Fagerström and Tom Eissenberg have described a continuum of dependence among tobacco and nicotine products. They concluded that cigarettes are the most dependence-producing (addictive) product and that smokeless tobacco is intermediate, evidenced by clinical trials showing that quitting cigarette smoking is more difficult than quitting ST.
In 2011, numerous local-government special-interest groups and elected officials fought against Gov. John Kasich’s proposed reduction to the Local Government Fund, a pool of taxpayers’ money collected by the state government and redistributed to local governments’ general revenue funds.
Swedish researchers from several institutions document that snus use is not associated with atrial fibrillation (commonly known as AFib), the most common heart arrhythmia (irregular timing of the heart beat) and a risk factor for stroke (abstract here). The same group previously reported that snus use conferred no significant risk for heart attack (discussed here) and stroke (here).
President Obama told America the morning of February 19 that if the sequester goes through on March 1: “It will eviscerate job-creating investments in education and energy and medical research….[…]
[First posted at Forbes.] It’s desperation time for global warming alarmists. Don’t believe me? Just look at what they’re parading as their best media story right now. They’re in a frenzy[…]
(This piece was first published at Forbes.com.) Jeopardy champion: “I’ll take ‘Science’ for $800, Alex.” Alex Trebek: “The answer is, ‘Inferior scientific literacy.’ ” Jeopardy champion: “What is one of[…]